Follow
Feng Yan
Title
Cited by
Cited by
Year
From reads to insight: a hitchhiker’s guide to ATAC-seq data analysis
F Yan, DR Powell, DJ Curtis, NC Wong
Genome Biology 21 (1), 22, 2020
3672020
Toll‐like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2
YD Liu, L Yu, L Ying, J Balic, H Gao, NT Deng, A West, F Yan, CB Ji, ...
International journal of cancer 144 (12), 3056-3069, 2019
422019
Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways
YD Liu, CB Ji, SB Li, F Yan, QS Gu, JJ Balic, L Yu, JK Li
International immunopharmacology 59, 375-383, 2018
382018
Green Tea Polyphenol EGCG Attenuates MDSCs-mediated Immunosuppression through Canonical and Non-Canonical Pathways in a 4T1 Murine Breast Cancer Model
P Xu, F Yan, Y Zhao, X Chen, S Sun, Y Wang, L Ying
Nutrients 12 (4), 1042, 2020
372020
PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers
L Ying, F Yan, Q Meng, L Yu, X Yuan, MP Gantier, BRG Williams, ...
Oncoimmunology 7 (6), e1433520, 2018
342018
Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods
X Li, R Tian, H Gao, F Yan, L Ying, Y Yang, P Yang, Y Gao
Technology in cancer research & treatment 17, 1533033818767455, 2018
342018
Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer
F Yan, L Ying, X Li, B Qiao, Q Meng, L Yu, X Yuan, ST Ren, DW Chan, ...
Oncotarget 8 (29), 47020, 2017
332017
Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry
L Ying, F Yan, Q Meng, X Yuan, L Yu, BRG Williams, DW Chan, L Shi, ...
Journal of translational medicine 15 (1), 1-11, 2017
322017
High‐dimensional analyses reveal a distinct role of T‐cell subsets in the immune microenvironment of gastric cancer
M Wang, YK Huang, JCH Kong, Y Sun, DG Tantalo, HXA Yeang, L Ying, ...
Clinical & Translational Immunology 9 (5), e1127, 2020
272020
(−)‐Epigallocatechin‐3‐gallate and EZH 2 inhibitor GSK 343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells
L Ying, F Yan, BRG Williams, P Xu, X Li, Y Zhao, Y Hu, Y Wang, D Xu, ...
Clinical and Experimental Pharmacology and Physiology 45 (1), 58-67, 2018
232018
Restricted cell cycle is essential for clonal evolution and therapeutic resistance of pre-leukemic stem cells
CS Tremblay, J Saw, SK Chiu, NC Wong, K Tsyganov, S Ghotb, ...
Nature communications 9 (1), 3535, 2018
182018
(‐)‐Epigallocatechin‐3‐gallate and atorvastatin treatment down‐regulates liver fibrosis‐related genes in non‐alcoholic fatty liver disease
L Ying, F Yan, Y Zhao, H Gao, BRG Williams, Y Hu, X Li, R Tian, P Xu, ...
Clinical and Experimental Pharmacology and Physiology 44 (12), 1180-1191, 2017
162017
In vitro antioxidant activity of phenolic-enriched extracts from Zhangping Narcissus tea cake and their inhibition on growth and metastatic capacity of 4T1 murine breast cancer …
L Ying, D Kong, Y Gao, F Yan, Y Wang, P Xu
Journal of Zhejiang University-SCIENCE B 19 (3), 199-210, 2018
102018
Identification of a Novel GRHL3/HOPX/Wnt/β-Catenin Proto-oncogenic Axis in Squamous Cell Carcinoma of the Esophagus
SR Georgy, DR Rudiatmoko, A Auden, D Partridge, T Butt, S Srivastava, ...
Cellular and Molecular Gastroenterology and Hepatology 15 (5), 1051-1069, 2023
82023
T-ALL can evolve to oncogene independence
H Abdulla, A Vo, BJ Shields, TJ Davies, JT Jackson, R Alserihi, EM Viney, ...
Leukemia 35 (8), 2205-2219, 2021
82021
Emerging Roles for Epigenetic Programming in the Control of Inflammatory Signaling Integration in Heath and Disease
Y Hu, F Yan, L Ying, D Xu
Regulation of Inflammatory Signaling in Health and Disease, 63-90, 2017
82017
Cancer patient stratification based on the tumor microenvironment
L Ying, F Yan, D Xu
Journal of Thoracic Disease 12 (8), 4522, 2020
62020
Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine
A Yeola, S Subramanian, RA Oliver, CA Lucas, JAI Thoms, F Yan, ...
Science Advances 7 (3), eabd1929, 2021
42021
A 9-gene score for risk stratification in B-cell acute lymphoblastic leukemia
F Yan, NC Wong, DR Powell, DJ Curtis
Leukemia 34 (11), 3070-3074, 2020
42020
CD137L and CD4 T cells limit BCL6‐expressing pre‐germinal center B cell expansion and BCL6‐driven B cell malignancy
Z Ding, I Quast, F Yan, Y Liao, C Pitt, K O‐Donnell, MJ Robinson, W Shi, ...
Immunology and cell biology 100 (9), 705-717, 2022
12022
The system can't perform the operation now. Try again later.
Articles 1–20